[Determination of a vector of therapy for weakness in incurable breast cancer patients based on the level of inflammatory response].

The weakness is one of the negative factors that degrade cancer patients’ quality of life. The nature of weakness may be multifactorial but among mechanisms of development of weakness a syndrome of chronic inflammation plays a crucial role. Therapy aimed at reducing of inflammation degree allows correcting other cancer-related symptoms and improving the quality of life of incurable patients.